Home Featured

Featured

Random

A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry

MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2023

New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate

Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions

Red Light Holland’s Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global Comedy Superstar Russell Peters, Accepted to Steam, the Largest Digital Distribution Platform for...

The Top 5 Psychedelic Clinical Trials of 2022

Israel-Based Clearmind Medicine Strengthening IP Portfolio with Three Provisional Patent Applications...

Wesana Announces Second Quarter 2022 Financial Results

Psychedelic Bulletin: Homecoming Raises $4m Seed; Angermayer Increases atai Stake by...

BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using...

Cybin Announces Additional Adelia Milestone Achievement

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel

How Safe is Ibogaine Therapy? The Delicate Balance of Risk and...

Psilocybin Enters German Psychiatry: A Clinical Milestone for Mental Health

Whole-Body Effects of Psychedelics Part 3 – The Heart

12 3...325 Page 1 of 325

EDITOR PICKS

Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers

Introducing The Psychedelic News Feed Podcast

Field Notes #5: ‘Psychedelics Week’ in Washington D.C.

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.